Skip to content
CNS Clinical Research

Washington

CNS clinical trials in Washington

91 CNS studies are recruiting participants at sites in 14 cities across Washington as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Washington city with a recruiting study

By research area: Depression (33), Parkinson's Disease (15), Multiple Sclerosis (12), Schizophrenia (11), ADHD (7), Epilepsy (6), Migraine (6), Bipolar Disorder (1).

Seattle (42), Bellevue (26), Everett (16), Spokane (9), Kirkland (8), Tacoma (4), Kenmore (2), Silverdale (2), Bellingham (1), Fort Lewis (1), Mercer Island (1), Pasco (1), Sedro-Woolley (1), Yakima (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Depression: recently updated in Washington

Basic details from each study's public record (the 12 most recently updated of 91). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

    • Phase 2
    • Ages 18 to 70
    • All sexes
    Sponsor
    Supernus Pharmaceuticals, Inc.
    Recruiting in
    Everett
    Registry record
    NCT07226661 · updated
  2. Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

    • No phase
    • Ages 12 to 22
    • All sexes
    Sponsor
    Michigan State University
    Recruiting in
    Seattle
    Registry record
    NCT06232304 · updated
  3. A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

    • Phase 3
    • Ages 18 to 85
    • All sexes
    Sponsor
    Cybin IRL Limited
    Recruiting in
    Seattle
    Registry record
    NCT06793397 · updated
  4. VOCALE LBD: Online Peer Support for Caregivers of People With Lewy Body Dementia

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Washington
    Recruiting in
    Seattle
    Registry record
    NCT07637097 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Washington on ClinicalTrials.gov.

Schizophrenia: recently updated in Washington

  1. A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

    • Phase 2
    • Ages 55 to 90
    • All sexes
    Sponsor
    MapLight Therapeutics
    Recruiting in
    Bellevue
    Registry record
    NCT06887192 · updated
  2. FAmily Engagement Strategy for Coordinated Specialty Care

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Washington State University
    Recruiting in
    Pasco · Tacoma · Yakima
    Registry record
    NCT06945055 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Washington on ClinicalTrials.gov.

ADHD: recently updated in Washington

  1. The Myelin Disorders Biorepository Project

    • Observational
    • All ages
    • All sexes
    Sponsor
    Children's Hospital of Philadelphia
    Recruiting in
    Seattle
    Registry record
    NCT03047369 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Washington on ClinicalTrials.gov.

Parkinson's disease: recently updated in Washington

  1. Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Boston Scientific Corporation
    Recruiting in
    Kirkland · Seattle · Spokane
    Registry record
    NCT02071134 · updated
  2. SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

    • Phase 1
    • Ages 40 to 80
    • All sexes
    Sponsor
    Serina Therapeutics
    Recruiting in
    Spokane
    Registry record
    NCT07422675 · updated
  3. A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Seattle
    Registry record
    NCT06841354 · updated
  4. A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Seattle · Spokane · Tacoma
    Registry record
    NCT06966700 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Washington on ClinicalTrials.gov.

Epilepsy: recently updated in Washington

  1. Biomarker Targeted Stimulation for Epileptiform Events

    • No phase
    • Ages 7 and older
    • Male participants
    Sponsor
    Cadence Neuroscience
    Recruiting in
    Seattle
    Registry record
    NCT06424977 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Washington on ClinicalTrials.gov.

Ask about studies in Washington

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call